Inventor · disambiguated record
Richard W. Scott
Also filed as: SCOTT RICHARD W · SCOTT RICHARD WILLIAM
25 granted patents·18 pending applications·423 citations·filing 1975–2023
96Inventor score
Files withCELLCEUTIX CORP9CEPHALON INC8SCOTT RICHARD W6INNOVATION PHARMACEUTICALS INC4POLYMEDIX INC4
Top patents by PatentIndex Score
43 records- 0194US5869336ARecombinant enzymatically active calpain expressed in a baculovirus systemCEPHALON INC·Filed 1997·Granted Feb 9, 1999·168 cites·9 claims
- 0293US8278309B2Synthetic mimetics of host defense and uses thereofDEGRADO WILLIAM F·Filed 2009·Granted Oct 2, 2012·16 cites·12 claims
- 0390US8975262B2Synthetic mimetics of host defense and uses thereofDEGRADO WILLIAM F·Filed 2012·Granted Mar 10, 2015·10 cites·2 claims
- 0489US9457027B2Compounds for use in treatment of mucostisCELLCEUTIX CORP·Filed 2015·Granted Oct 4, 2016·6 cites·15 claims
- 0588US9795575B2Compounds for use in treatment of mucositisCELLCEUTIX CORP·Filed 2016·Granted Oct 24, 2017·5 cites·20 claims
- 0687US9469616B2Cyclic compounds and methods of making and using the sameCELLCEUTIX CORP·Filed 2012·Granted Oct 18, 2016·5 cites·19 claims
- 0787US9155738B2Compounds for use in treatment of mucostitisCELLCEUTIX CORP·Filed 2014·Granted Oct 13, 2015·7 cites·16 claims
- 0887US8802683B2Compounds for use in treatment of mucositisSCOTT RICHARD W·Filed 2012·Granted Aug 12, 2014·9 cites·22 claims
- 0986US9192623B2Arylamide compounds and compositions and uses thereofCELLCUTIX CORP·Filed 2012·Granted Nov 24, 2015·9 cites·21 claims
- 1085US10166232B2Arylamide compounds and compositions and uses thereofCELLCEUTIX CORP·Filed 2015·Granted Jan 1, 2019·3 cites·10 claims
- 1184US10206894B2Compounds for use in treatment of mucositisINNOVATION PHARMACEUTICALS INC·Filed 2017·Granted Feb 19, 2019·3 cites·18 claims
- 1284US8796275B2Anti-malarial compoundsSCOTT RICHARD W·Filed 2009·Granted Aug 5, 2014·6 cites·20 claims
- 1383US5521086ASecretion sequence for the production of a heterologous protein in yeastCEPHALON INC·Filed 1993·Granted May 28, 1996·60 cites·18 claims
- 1482US5814300AGene-targeted non-human mammals deficient in the SOD-1 geneCEPHALON INC·Filed 1995·Granted Sep 29, 1998·48 cites·4 claims
- 1575US8895561B2Compounds and methods for treating candidiasis and aspergillus infectionsCELLCEUTIX CORP·Filed 2013·Granted Nov 25, 2014·4 cites·4 claims
- 1672US8987551B2Modified oil encapsulating proteins and uses thereofROBERTS NICHOLAS JOHN·Filed 2012·Granted Mar 24, 2015·3 cites·54 claims
- 1771US2021093636A1Arylamide compounds and compositions and uses thereofINNOVATION PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1870US10603294B2Compounds for use in treatment of mucositisINNOVATION PHARMACEUTICALS INC·Filed 2019·Granted Mar 31, 2020·0 cites·13 claims
- 1970US6057143ARecombinant enzymatically active calpain expressed in a baculovirus systemCEPHALON INC·Filed 1997·Granted May 2, 2000·22 cites·19 claims
- 2070US2010144761A1Antimicrobial Molecules For Treating Multi-Drug Resistant And Extensively Drug Resistant Strains Of MycobacteriumPOLYMEDIX INC·Filed 2009·Application pending·0 cites
- 2163US9957519B2Acyltransferase polynucleotides, polypeptides and methods of useAGRESEARCH LTD·Filed 2013·Granted May 1, 2018·1 cites·30 claims
- 2263US2019314370A1Arylamide compounds and compositions and uses thereofINNOVATION PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2362US2009092574A1Ophthalmic And Otic Compositions Of Facially Amphiphilic Polymers And Oligomers And Uses ThereofSCOTT RICHARD W·Filed 2007·Application pending·0 cites
- 2460US3958213AAdaptive gain control and method for signal processorGTE SYLVANIA INC·Filed 1975·Granted May 18, 1976·16 cites·13 claims
- 2559US2025332276A1Inhibitors of Molluscum Contagiosum Infection and Methods Using the SameUNIV PENNSYLVANIA·Filed 2023·Application pending·0 cites
- 2658US6734336B1Gene-targeted non-human mammal with human fad presenilin mutation and generational offspringCEPHALON INC·Filed 2000·Granted May 11, 2004·3 cites·40 claims
- 2757US2015072997A1Anti-malarial compoundsCELLCEUTIX CORP·Filed 2014·Application pending·0 cites
- 2856US2013137706A1Antimicrobial Molecules For Treating Multi-Drug Resistant and Extensively Drug Resistant Strains Of MycobacteriumPOLYMEDIX INC·Filed 2012·Application pending·0 cites
- 2956US2009081153A1Combination of synthetic antimicrobial polymers and sesquiterpenoid compoundsPOLYMEDIX INC·Filed 2008·Application pending·0 cites
- 3056US2025295652A1Inhibitors of Molluscum Contagiosum Infection and Methods Using the SameUNIV PENNSYLVANIA·Filed 2022·Application pending·0 cites
- 3153US2023235301A1Compounds and Methods for Treating, Ameliorating, or Preventing Herpes Ocular KeratitisUNIV PENNSYLVANIA·Filed 2021·Application pending·0 cites
- 3252US5777194AGene-targeted mice with humanized Aβ sequence and Swedish FAD mutationCEPHALON INC·Filed 1996·Granted Jul 7, 1998·16 cites·5 claims
- 3351US9896694B2Acyltransferase polynucleotides, polypeptides and methods of useAGRESEARCH LTD·Filed 2013·Granted Feb 20, 2018·0 cites·44 claims
- 3450US2014162955A1Antagonizing Heparin With Salicylamide Compounds And Histamine Blocking AgentsSCOTT RICHARD W·Filed 2013·Application pending·0 cites
- 3550US2024018121A1Novel heteroaromatic compounds exhibiting antifungal activity and their method of useFOX CHASE CHEMCIAL DIVERSITY CENTER INC·Filed 2021·Application pending·0 cites
- 3650US2004154047A1Gene-targeted non-human mammal with human FAD presenilin mutation and generational offspringCEPHALON INC·Filed 2004·Application pending·0 cites
- 3748US2016287586A1Compounds and methods for treating candidiasis and aspergillus infectionsCELLCEUTIX CORP·Filed 2014·Application pending·0 cites
- 3841US2012115877A1Facially Amphiphilic Compounds, Compositions, And Uses Thereof In Treating CancerSCOTT RICHARD W·Filed 2011·Application pending·0 cites
- 3940US2015094294A1Compounds and methods for treating malariaCELLCEUTIX CORP·Filed 2013·Application pending·0 cites
- 4038US11312971B2Enhanced acyltransferase polynucleotides, polypeptides and methods of useAGRESEARCH LTD·Filed 2013·Granted Apr 26, 2022·0 cites·27 claims
- 4135US2012258141A9Methods Of Immune ModulationSCOTT RICHARD W·Filed 2011·Application pending·0 cites
- 4235US2011178104A1Anti-Heparin CompoundsPOLYMEDIX INC·Filed 2011·Application pending·0 cites
- 4332US6284944B1Gene-targeted non-human mammal with a human fad presenilin mutation and generational offspringCEPHALON INC·Filed 1998·Granted Sep 4, 2001·3 cites·10 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →